Sparrow Pharmaceuticals
No bio yet
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Sparrow Pharmaceuticals
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical development.